Treatment of acute idiopathic thrombocytopenia of childhood with intravenous infusions of gammaglobulin.
Treatment of acute idiopathic thrombocytopenia of childhood with intravenous infusions of gammaglobulin.
复制标题
静脉输注丙种球蛋白治疗儿童急性特发性血小板减少症。
DOI:
10.1016/s0022-3476(85)80231-6
复制
发表时间:
1985
期刊:
影响因子:
--
通讯作者:
M. Hilgartner
中科院分区:
文献类型:
--
作者:
J. Bussel;J. Bussel;Alice Goldman;Alice Goldman;P. Imbach;P. Imbach;I. Schulman;I. Schulman;M. Hilgartner;M. Hilgartner
Gammaglobulin treatment was given at a dose of 1 mg/kg/day intravenously in 29 patients with acute idiopathic thrombocytopenic purpura: 15 previously untreated, 10 resistant to steroids, and four who were steroid dependent. The average platelet increase in 24 hours was >50,000/μl; the average peak platelet count was 194,000/μl. Eighteen of 25 patients required only one infusion; 10 of these 18 never required any additional (maintenance) therapy. Outcome in previously untreated and steroid-resistant patients was identical; however, previously untreated patients required only 1.8 gm/kg total dose of gammaglobulin, whereas steroid-resistant patients received 3.9 gm/kg. Only one steroid-dependent child of the 29 patients still requires maintenance therapy, at 6-week intervals. Toxicity was minimal. Cost was minimized by not admitting patients and by giving treatment in one visit, rather than five.